Dr. Poznansky gives an invited research talk about latest advances at VIC with the development of a novel self-assembling vaccine platform at the Vaccines R and D international summit in Boston this month. This work is partnered with Voltron Therapeutics Inc. The company and its leadership are supporting product development and progress towards first in human studies with a self-assembling vaccine for cervical and head and neck cancer.